Cellectar Biosciences, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

RESTRUCTURING COSTS AND OTHER CORPORATE CHANGES (Details Textual)

RESTRUCTURING COSTS AND OTHER CORPORATE CHANGES (Details Textual) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Restructuring Cost and Reserve [Line Items]
Severance Costs	$ 160,000us-gaap_SeveranceCosts1
Restructuring Costs, Total	221,816us-gaap_RestructuringCosts	1,096,874us-gaap_RestructuringCosts
Restructuring Charges		1,097,000us-gaap_RestructuringCharges
Severance And Retention Expense [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Charges		386,000
Stock Based Compensation Expense Related To Modification Of Options [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Charges	48,000	706,000
Other Administrative Expense [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Charges		5,000
Newton office [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Charges	$ 14,000

- Definition

Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.

+ References + Details

- Definition

Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.

+ References + Details